Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April
Bloomberg Michelle F Davis
Related Coverage
- Benchling adds another megaround into the fold, looking even more unicorn-y as a possible IPO approaches ENDPOINTS NEWS
- Cloud R&D developer Benchling picks up second nine-figure venture capital haul this year FierceBiotech
- Benchling Raises $100M in Series F Financing Co-Led by Altimeter and Franklin Templeton PR Newswire
- Life sciences software startup Benchling files for U.S. listing -sources Reuters
- Biotech R&D Platform Benchling Closes $100M at $6B Valuation hitconsultant.net
Discussion
-
@benchling
@benchling
on x
We announced our Series F, which we'll use to keep powering #biotech R&D. Check out @business to see how our customers are tackling humanity's most pressing challenges as they develop new medicines, crops & other breakthrough products faster than ever.👨🏾🔬 👩🏼🔬 https://www.bloomb…
-
@agoulburn
Adam Goulburn
on x
Biology + drug discovery is scaling & automating at an accelerated rate never seen before @benchling is the software infrastructure layer leading that digitization. Kudos to Saji & his world class team! 🚀🚀🚀 @BrandonReeves08 👊 https://www.bloomberg.com/... https://twitter.com/...
-
@svangel
SV Angel
on x
We are thrilled for @sajithw and team @benchling on their Series F announcement as they continue to help scientists solve today's global challenges. They're also hiring! https://benchling.com/... https://twitter.com/...
-
@menloventures
@menloventures
on x
We congratulate @sajithw and the team at @Benchling on this milestone funding. We've long supported their mission to accelerate the process to bring new biologic products to market, with automation, software, and ML. https://www.bloomberg.com/...
-
@deenashakir
Deena Shakir
on x
Congratulations to @Lux_Capital portfolio company @benchling on this next chapter to continue to power biotech innovation through software! Having the chance to learn from afar from Founder/CEO @sajithw has been an incredible privilege. https://twitter.com/...
-
@zachtratar
Zach Tratar
on x
Biotechnology, such as mRNA vaccines & CRISPR, is still incredibly early — it will come to define the next couple decades, just like the internet defined the last ~20 years. Benchling is the R&D operating system accelerating this bend in history. I could see it hitting $100B+. ht…
-
@brandonreeves08
Brandon Reeves
on x
Congrats to @benchling team! At a $6.1B Series F what people may not realize is Benchling is still early in its chapters and will increasingly become one of the most important software platforms powering one of our most important industries (pharma/biotech) cc:@sajithw @daashu ht…
-
@malayhgandhi
Malay Gandhi
on x
I'm hiring for corporate strategy, market strategy, corporate development, and business development (product/technical partnerships). Reach out if you're passionate about the century of biology! https://twitter.com/...
-
@willreed_21
Will Reed
on x
Biotech is transforming the world and scientists need R&D software designed for the new speed of science. All of us @sparkcapital are proud to continue to support @Benchling and their mission to help breakthrough products get to market faster. https://www.bloomberg.com/...
-
@zavaindar
Zavain Dar
on x
Every layer of the discovery and development stack will be redesigned with automation, software, machine learning, and of course, cutting edge molecular biology and biochemistry. @Lux_Capital backed @Benchling led by @sajithw showing the way: https://www.bloomberg.com/... https:/…